IP Verse

Curevac patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Curevac opposed by its competitors

Explore Curevac's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3283059
Jan 3, 2024Method For Producing Rna Compositions7
EP4155409
Dec 27, 2023Method Of Increasing The Replication Of A Circular Dna Molecule4
EP4108769
Aug 30, 2023A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow Filtration5
EP4023755
Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3521456
Jan 4, 2023Methods And Means For Enhancing Rna Production3
EP3708668
Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3283125
Dec 29, 2021Lyophilization Of Rna2
EP3115064
Nov 24, 2021Rna-Coded Antibody1
EP2680880
Nov 10, 2021Vaccination In Newborns And Infants1
EP3297682
Jul 14, 2021Dry Powder Composition Comprising Long-Chain Rna2

Top competitors of Curevac

Top competitors of Curevac based on patent oppositions.